Acesynerzys Pharmalinks LLP

Acesynerzys Pharmalinks LLP - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
LLPIN AAK-3457 Incorporated 18 August 2017 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Limited Liability Partnership pharma
Data last updated
Contribution obligation
₹20,000
As per LLP agreement
LLP age
9 yrs
Est. 2017
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Mumbai
ROC office
Incorporated
18 Aug 2017
Date of incorporation
Entity type
LLP
As registered with MCA

About Acesynerzys Pharmalinks LLP

Data last updated:

Acesynerzys Pharmalinks LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 August 2017 and has been in existence for over 9 years.

The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAK-3457.

The LLP has a total obligation of contribution of ₹20,000. It is led by designated partners Dhruv Arora Harish and Kaushal Kirtikumar Shah.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 703 Venus – 1 Cosmos Regency Waghbil Ghodbunder Road, Mumbai, Maharashtra, India – 400607.

Company Details of Acesynerzys Pharmalinks LLP
LLPIN AAK-3457
Incorporation Date 18 August 2017
Total Obligation of Contribution ₹20,000
ROC Mumbai
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    703 Venus – 1 Cosmos Regency Waghbil Ghodbunder Road, Mumbai, Maharashtra, India – 400607
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Acesynerzys Pharmalinks LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Acesynerzys Pharmalinks LLP report

Financials, compliance, directors, charges, ownership and filings for Acesynerzys Pharmalinks LLP in one report.

Financials from FY 2018 Directors & ownership Charges & compliance

Financials of Acesynerzys Pharmalinks LLP FY 2025 filings available

Financial Statement Summary of Acesynerzys Pharmalinks LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax••••••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Acesynerzys Pharmalinks LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin••••••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Acesynerzys Pharmalinks are in the company report.

Premium access

Financial statements from FY 2018

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Acesynerzys Pharmalinks LLP

Acesynerzys Pharmalinks has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Dhruv Arora HarishDesignated Partner02 Feb 20197 Years 8 MonthsCurrent
Kaushal Kirtikumar ShahDesignated Partner18 Aug 20179 Years 1 MonthsCurrent

Charges & Borrowings of Acesynerzys Pharmalinks LLP

Acesynerzys Pharmalinks LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Acesynerzys Pharmalinks LLP

Employment history and EPFO contributions of people linked to Acesynerzys Pharmalinks.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Acesynerzys Pharmalinks LLP

Acesynerzys Pharmalinks LLP has 3 designated partner changes on record since 2017: 2 appointments and 1 cessation. The latest: Dhruv Arora Harish was appointed as Designated Partner on 02 Feb 2019.

AGM
Acesynerzys Pharmalinks Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Acesynerzys Pharmalinks Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Dhruv Arora Harish was appointed as Designated Partner.
Ceased
Khushwant Bansal ceased to be Designated Partner.
Appointed
Kaushal Kirtikumar Shah was appointed as Designated Partner.
Incorporation
18 Aug 2017
Acesynerzys Pharmalinks Llp was registered on 18 Aug 2017 with Roc Mumbai & aged 9 years 1 month as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Acesynerzys Pharmalinks LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Acesynerzys Pharmalinks LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Acesynerzys Pharmalinks LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Acesynerzys Pharmalinks LLP

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Acesynerzys Pharmalinks LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Acesynerzys Pharmalinks LLP

Acesynerzys Pharmalinks is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 August 2017 (9+ years old) and is registered under LLPIN AAK-3457.

Acesynerzys Pharmalinks has 2 current designated partners:

The LLPIN (Limited Liability Partnership Identification Number) of Acesynerzys Pharmalinks is AAK-3457. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Acesynerzys Pharmalinks was incorporated on 18 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.

Dhruv Arora Harish was appointed as Designated Partner on 02 Feb 2019. Khushwant Bansal ceased to be Designated Partner on 02 Feb 2019. Kaushal Kirtikumar Shah was appointed as Designated Partner on 18 Aug 2017.

The registered office of Acesynerzys Pharmalinks is at 703 Venus – 1 Cosmos Regency Waghbil Ghodbunder Road, Mumbai, Maharashtra, India – 400607.

The total obligation of contribution is ₹20,000.

Acesynerzys Pharmalinks operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Acesynerzys Pharmalinks can be reached at its registered office: 703 Venus – 1 Cosmos Regency Waghbil Ghodbunder Road, Mumbai, Maharashtra, India – 400607.

Acesynerzys Pharmalinks is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available